Ivermectin for Mild to Moderate COVID-19, Persistent Symptoms Following COVID-19, Review of Hypercalcemia, and more episode artwork

EPISODE · Oct 25, 2022 · 10 MIN

Ivermectin for Mild to Moderate COVID-19, Persistent Symptoms Following COVID-19, Review of Hypercalcemia, and more

from JAMA Editors' Summary

Editors' Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 25, 2022, issue.

Episode metadata supplied by the publisher feed · Published Oct 25, 2022

Embed this episode

NOW PLAYING

Ivermectin for Mild to Moderate COVID-19, Persistent Symptoms Following COVID-19, Review of Hypercalcemia, and more

0:00 10:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 10 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on October 25, 2022.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!